Go Bust MIC

Go MICBUSTERS

MICBUSTERS · Technology comparison · 2 / 5

Retego vs BactiQuant: Similar Enzyme Principles, Different Test Claims

Retego’s enzyme-based microbiology methods may look familiar to people who have used BactiQuant. That is a reasonable technical comparison. The useful question is which measurement principles overlap, where the assays differ, and whether either result supplies the biological detail required for a MIC decision.

Evidence checked: 26 October 2026 · By MICBUSTERS · Retego technology series

Direct answer

BactiQuant and the total-bacteria enzyme assay described in the 2026 Retego-related paper share a broad approach: generate an optical signal from bacterial enzyme activity. Retego’s SRB method additionally combines an enzyme-related response with H₂S detection. The public documents reviewed do not establish identical formulations, equivalent performance or copying.

Discuss on-site qPCR for your samples →

What is the shared measurement principle?

Both approaches belong to a broader family of biochemical assays. A supplied substrate reacts with an enzyme and produces an optical response. The response is used as a proxy for a biological property. This is distinct from growing a culture, counting intact cells or amplifying a selected DNA sequence.

BactiQuant’s manufacturer describes a fluorescence-labelled substrate that releases a soluble fluorophore through enzyme activity of predominantly bacterial origin. In the mobile filtration workflow, bacteria are concentrated from a known water volume before the enzymatic signal is read. The result is a broad bacterial-bioburden indicator. [1]

The total-bacteria assay described in the 2026 conference paper also uses filtration and an enzyme-related optical signal, with normalisation for volume, temperature and reaction time. That is a substantive similarity in the measurement chain. The paper does not establish that the commercial reagents, substrate specificity or calibration are the same. [2]

Is enzyme-based bacterial monitoring a new idea?

No. EPA/Battelle verification testing of Bactiquant took place in 2011, with a verification statement signed in 2012. The programme examined analytical properties such as linearity, repeatability and inter-assay reproducibility in specified test waters. Verification is performance testing within a defined scope, not a product endorsement or validation of every field interpretation. [3]

That history establishes that enzyme-generated fluorescence was already a documented route to rapid bacterial screening. It does not answer questions about product ownership, licensing or the exact relationship between commercial suppliers. Similar operating principles alone cannot establish those relationships.

For an asset owner, a more useful comparison is the declared measurand: what physical or biological quantity is the method intended to measure, and how is that quantity linked to the reported result?

How does the Retego SRB method differ from a broad bacterial assay?

Compare assay scope before comparing speed or numerical results
AspectBactiQuant broad bacterial assayRetego SRB method described in 2026
Primary interpretationBroad bacterial bioburden from enzyme activity.An SRB indication from combined biochemical criteria.
Signal logicEnzyme-generated fluorescence, standardised for the method.Enzyme-related fluorescence plus an H₂S response.
Biological identityNot a species or functional-gene identification method.Not a DNA sequence or species identification method.
Important evidence questionHow well does the signal track bacterial loading in this matrix?How selective and reproducible is the combined SRB classification in this matrix?
MIC boundaryDoes not measure corrosion or identify its mechanism.Does not measure corrosion or identify a corrosion-associated gene.

The SRB application therefore adds a different interpretation layer. It should not be dismissed as merely a total-bacteria reading with a new label. Equally, calling a test “SRB-specific” does not by itself document its biological coverage or the selectivity of every underlying reagent. Those questions require challenge testing. [2]

What can the Retego patent application tell us?

The patent application cited in the conference paper describes combining H₂S detection, enzymatic activity and oxygen management. It includes several possible enzyme substrates and optical implementations. Such a disclosure can explain the design space without identifying the exact formulation in a particular commercial kit. [4]

The paper associates the SRB method with dissimilatory sulfite reductase. The broader patent disclosure is not enough to independently establish that every commercial fluorescence response is a direct measurement of that one enzyme. The appropriate next evidence is an assay-specific selectivity study, not an inference from the patent title.

For this reason, a scientifically careful comparison says “a shared class of enzyme-based detection principles” rather than “the same test”. It also keeps patent disclosure separate from independent analytical validation.

Does enzyme activity mean that every detected bacterium is alive?

Not automatically. “Viable”, “culturable”, “membrane-intact” and “enzymatically active” describe different properties. A biochemical signal indicates that a reaction occurred under the assay conditions. Interpreting that signal as a count of living cells requires validation for the organisms and treatment conditions involved.

The EPA technology brief’s description of the historical Bactiquant assay explicitly includes enzyme activity from viable and some non-viable bacteria. That is evidence about that assay, not a measured live/dead performance result for Retego. It does show why a general claim that all enzyme methods detect only living organisms is too broad. [5]

Standard DNA qPCR has its own clear limitation: recoverable DNA can persist after inactivation. These limitations should be stated symmetrically. For treatment assessment, use the existing MICBUSTERS guide to DNA qPCR, viability and biocide verification, rather than assuming that any single endpoint is a complete kill measurement.

Why choose qPCR when the investigation needs more than a broad signal?

The value of qPCR is the specificity of the question. A selected assay can examine a microbial group or functional gene rather than combine all responding organisms into one enzyme-derived reading. Several targets can be applied to a sample to separate broad community information from narrower mechanism-associated evidence.

For a MIC investigation, that can mean distinguishing a sulfate-reduction target from methanogenic targets, or adding a selected corrosion-associated biomarker when general counts are inconclusive. Published work on micC illustrates that narrower approach; it does not make every positive marker result a diagnosis of corrosion. [6]

qPCR results still require appropriate recovery, inhibition and contamination controls. The case for qPCR is strongest when that extra biological detail changes the sampling or integrity decision. A faster broad screening result may remain valuable alongside it.

Compare the biological information your monitoring programme needs →

Your samples. Your decision.

Need more than a total bacterial signal?

Discuss whether a targeted qPCR panel would help distinguish the microbial groups or functional genes relevant to your asset.

  1. Leave your work email.
  2. We follow up about your system, sample and monitoring question.
  3. Discuss whether on-site qPCR is a useful next step.

Discuss my MIC samples

Your email lets us reply to this enquiry. Read our privacy policy.

Prefer to explain your question now? Use the contact page.

Frequently asked questions

Is Retego a copy of BactiQuant?

The reviewed public evidence does not establish that. Similar enzyme-generated optical signals demonstrate a shared technology class, not identical chemistry, ownership or performance.

Can BactiQuant identify sulfate-reducing bacteria?

The broad bacterial assay described here does not identify an SRB population or selected sulfate-reduction genes. An additional assay is needed for that question.

Can enzyme assay values be converted directly to qPCR copies?

No universal conversion is valid. The methods measure different biological properties, and their outputs depend on calibration, target biology, recovery and sample conditions.

Privacy Overview
Logo

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. For more information visit our Privacy Policy page.

Necessary Cookies

Necessary Cookie required the page to work properly and save your preferences for cookie settings.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.